Lucia C. Petito

Lucia C. Petito

Auto-generated profile, based on publicly available information

Lucia C. Petito

Northwestern University Feinberg School of Medicine

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Journal of Surgical Education
Verified
Journal Article
Closed access
BGBrian C. George
Brian C. George
ETEzra N. Teitelbaum
Ezra N. Teitelbaum
SMShari L. Meyerson
Shari L. Meyerson
MSMary C. Schuller
Mary C. Schuller
DDDebra A. DaRosa
Debra A. DaRosa
JFJonathan P. Fryer
Jonathan P. Fryer

3 July 2018 in Annals of Internal Medicine
Verified
Journal Article
Closed access
HKHormuzd A. Katki
Hormuzd A. Katki
SKStephanie A. Kovalchik
Stephanie A. Kovalchik
LPLucia C. Petito
Lucia C. Petito
LCLi C. Cheung
Li C. Cheung
EJEric Jacobs
Eric Jacobs
ACAnil K. Chaturvedi
Anil K. Chaturvedi
Guidelines recommend the use of individualized risk models to refer ever-smokers for lung cancer screening, but the performance of different models in selecting ever-smokers for screening is unknow... Background: Lung cancer screening guidelines recommend using individualized risk models to refer ever-smokers for screening. However, different models select different screening populations. The pe...

1 June 2020 in Patterns
Verified
Journal Article
Open access
SMSean McGrath
Sean McGrath
VLVictoria Lin
Victoria Lin
ZZZilu Zhang
Zilu Zhang
LPLucia C. Petito
Lucia C. Petito
RLRoger W. Logan
Roger W. Logan
JYJessica G. Young
Jessica G. Young
Researchers are often interested in estimating the causal effects of sustained treatment strategies, i.e., of (hypothetical) interventions involving time-varying treatments. When using observational data, estimating those effects requires adjustment for confounding. However, conventional regression methods cannot appropriately adjust for confounding in the presence of treatment-confounder feedback. In contrast, estimators derived from Robins’s g-formula may correctly adjust for confounding even if treatment-confounder feedback exists. The package gfoRmula implements in R one such estimator: the parametric g-formula. This estimator can be used to estimate the effects of binary or continuous time-varying treatments as well as contrasts defined by static or dynamic, deterministic, or random interventions, as well as interventions that depend on the natural value of treatment. The package accommodates survival outcomes as well as binary or continuous outcomes measured at the end of follow-up. This paper describes the gfoRmula package, along with motivating background, features, and examples.

2 March 2020 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
LPLucia C. Petito
Lucia C. Petito
XGXabier García-Albéniz
Xabier García-Albéniz
RLRoger W. Logan
Roger W. Logan
NHNadia Howlader
Nadia Howlader
AMAngela B. Mariotto
Angela B. Mariotto
MHMiguel A. Hernán
Miguel A. Hernán
When randomized clinical trials are not available at the time a clinical decision needs to be made, clinicians often must choose between making decisions based on either observational data or no human data at all. A cautious use of observational data has been recently endorsed by the American Society of Clinical Oncology, which states that observational studies can “inform questions that either have not been or cannot be answered by randomized trials”1(p1845) and “complement the evidence collected in randomized trials.”1(p1845) Observational studies may be particularly important for patients who are underrepresented in trials, such as elderly patients.2,3

1 March 2017 in Health & Place
Verified
Journal Article
Closed access
MMMahasin Mujahid
Mahasin Mujahid
LMLatetia V. Moore
Latetia V. Moore
LPLucia C. Petito
Lucia C. Petito
Kiarri KershawKiarri Kershaw
Kiarri Kershaw
KWKarol Watson
Karol Watson
ARAna V. Diez Roux
Ana V. Diez Roux

1 May 2020 in Epidemiology
Verified
Journal Article
Closed access
IDIssa J. Dahabreh
Issa J. Dahabreh
LPLucia C. Petito
Lucia C. Petito
SRSarah E. Robertson
Sarah E. Robertson
MHMiguel A. Hernán
Miguel A. Hernán
JSJon A. Steingrimsson
Jon A. Steingrimsson
We take steps toward causally interpretable meta-analysis by describing methods for transporting causal inferences from a collection of randomized trials to a new target population, one trial at a time and pooling all trials. We discuss identifiability conditions for average treatment effects in the target population and provide identification results. We show that the assumptions that allow inferences to be transported from all trials in the collection to the same target population have implications for the law underlying the observed data. We propose average treatment effect estimators that rely on different working models and provide code for their implementation in statistical software. We discuss how to use the data to examine whether transported inferences are homogeneous across the collection of trials, sketch approaches for sensitivity analysis to violations of the identifiability conditions, and describe extensions to address nonadherence in the trials. Last, we illustrate the proposed methods using data from the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial.